A microtiter assay for quantifying protein-protein interactions associated with cell-cell adhesion

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Cell-cell adhesions, particularly involving E-cadherin and beta-catenin, are vital for epithelial tissue integrity.
• Disruption of these cell adhesions is a critical factor in oncogenesis, observed in both early and late cancer stages.
• Current methods for analyzing E-cadherin:beta-catenin complexes are low-throughput and lack quantitative precision.

Purpose of the Study:

• To develop and validate a novel protein complex enzyme-linked immunosorbent assay (ELISA) for quantifying E-cadherin:beta-catenin interactions.
• To establish a quantitative method for assessing molecular changes in adherens junctions in cancer cell biology.
• To explore the potential of this assay as a prognostic marker for tumor progression.

Main Methods:

• Development of a protein complex ELISA to measure beta-catenin bound to E-cadherin in whole-cell lysates.
• Validation of the assay with a Z' factor of 0.74, indicating high assay quality.
• Integration of the protein complex ELISA with traditional sandwich ELISAs for parallel measurement of total E-cadherin and beta-catenin levels.

Main Results:

• The developed ELISA accurately quantifies E-cadherin:beta-catenin complexes in unpurified whole-cell lysates.
• The assay demonstrated high quantitative performance, surpassing existing low-throughput methods.
• Case studies in cancer cell biology provided detailed molecular insights into adherens junction changes in vivo.

Conclusions:

• The novel protein complex ELISA offers a significant advancement for studying E-cadherin:beta-catenin interactions.
• This quantitative assay enables a detailed understanding of molecular alterations within adherens junctions.
• The E-cadherin:beta-catenin protein complex ELISA holds potential as a valuable quantitative prognostic marker in oncology.